European Commissions signs deal with Gilead to secure access to remdesivir

The European Commission announced that it signed a deal with Gilead Sciences to secure access to the coronavirus drug remdesivir, as reported by Reuters.

Market reaction

This development doesn’t seem to be having a significant impact on market sentiment. As of writing, the Euro Stoxx 50 Index was virtually unchanged at 3,302 and Germany’s DAX 30 Index was down 0.15% at 12,814. 

Meanwhile, the EUR/USD pair, which touched a daily high of 1.1769, was last seen gaining 0.28% on the day at 1.1745.